CJC-1295 with DAC has a half-life of approximately 68 days
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al
Each capsule contains precisely measured 50mg dose enabling consistent research protocols
Neuroscience letters
Benefits include improved exercise performance and potential weight loss support
The FDA has approved a growing number of medications for weight management, including Xenical (orlistat), Alli (orlistat), Qsymia (phentermine-topiramate), Contrave (bupropion-naltrexone), Saxenda (liraglutide), Imcivree (setmelanotide), Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo (orforglipron)